Expression Profile of the Polycomb Group Protein Enhancer of Zeste Homologue 2 and its Prognostic Relevance in Renal Cell CarcinomaStefan Hinz, Carsten Kempkensteffen, Steffen Weikert et al.|The Journal of Urology|2009Cited by 50
Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinomaMadeleine Sassenberg, Michèle J. Hoffmann|BMC Cancer|2019Cited by 47
Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladderStefan Hinz, Steffen Weikert, Hans Krause et al.|Journal of Cancer Research and Clinical Oncology|2007Cited by 38
Predictive value of molecular subtypes and <i>APOBEC3G</i> for adjuvant chemotherapy in urothelial bladder cancerCsilla Oláh, Tibor Szarvas, Eszter Székely et al.|Cancer Medicine|2022Cited by 14
A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer—Stromal gene expressions show higher prognostic values than intrinsic tumor genesCsilla Oláh, Tibor Szarvas, Christina Hahnen et al.|International Journal of Cancer|2021Cited by 9